secwatch.observer — SEC 8-K summary
======================================

Issuer:     LivaNova PLC (LIVN)
CIK:        0001639691
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0001639691-25-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LivaNova Q4 revenue $321.8M (+6.8% organic); FY2025 adjusted EPS guidance $3.65-$3.75
--------------------------------------------------------------------------------

- Q4 revenue $321.8M (+6.8% organic YoY); GAAP EPS $1.02, adjusted EPS $0.81.
- FY2024 revenue $1.25B (+10.7% organic); GAAP EPS $1.16, adjusted EPS $3.38.
- FY2025 guidance: constant-currency revenue growth 5-6%, adjusted EPS $3.65-$3.75, adjusted FCF $135-155M.
- OSPREY sleep apnea study met primary safety and efficacy endpoints at 6 months; RECOVER depression study publications support VNS Therapy.
- Natalia Kozmina appointed Chief Human Resources Officer in January 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1639691/000163969125000008/0001639691-25-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1639691/000163969125000008/livn-20250225.htm
  HTML page:      https://secwatch.observer/filing/0001639691-25-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer